1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 HOUSE BILL 1311 By: Humphrey
4
5
6 AS INTRODUCED
7 An Act relating to controlled dangerous substances;
amending 63 O.S. 2021, Section 2-204, as last amended
8 by Section 3, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
2024, Section 2-204), which relates to the Uniform
9 Controlled Dangerous Substances Act; adding chemicals
to Schedule I; and providing an effective date.
10
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-204, as
15 last amended by Section 3, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
16 2024, Section 2-204), is amended to read as follows:
17 Section 2-204. The controlled substances listed in this section
18 are included in Schedule I and include any material, compound,
19 mixture or preparation that contains any quantity of the following
20 hallucinogenic substances, their salts, isomers and salts of
21 isomers, unless specifically excepted, when the existence of these
22 salts, isomers and salts of isomers is possible within the specific
23 chemical designation.
24
Req. No. 10084 Page 1

1 A. Any of the following opiates including their isomers,
2 esters, ethers, salts, and salts of isomers, esters, and ethers,
3 unless specifically excepted, when the existence of these isomers,
4 esters, ethers, and salts is possible within the specific chemical
5 designation:
6 1. Acetylmethadol;
7 2. Allylprodine;
8 3. Alphacetylmethadol;
9 4. Alphameprodine;
10 5. Alphamethadol;
11 6. Benzethidine;
12 7. Betacetylmethadol;
13 8. Betameprodine;
14 9. Betamethadol;
15 10. Betaprodine;
16 11. Clonitazene;
17 12. Dextromoramide;
18 13. Dextrorphan (except its methyl ether);
19 14. Diampromide;
20 15. Diethylthiambutene;
21 16. Dimenoxadol;
22 17. Dimepheptanol;
23 18. Dimethylthiambutene;
24 19. Dioxaphetyl butyrate;
Req. No. 10084 Page 2

1 20. Dipipanone;
2 21. Ethylmethylthiambutene;
3 22. Etonitazene;
4 23. Etoxeridine;
5 24. Furethidine;
6 25. Hydroxypethidine;
7 26. Isotonitazene;
8 27. Ketobemidone;
9 28. Levomoramide;
10 29. Levophenacylmorphan;
11 30. Metonitazene;
12 31. Morpheridine;
13 32. N-desethyl isotonitazene;
14 33. N-pyrrolidino protonitazene;
15 34. Noracymethadol;
16 35. Norlevorphanol;
17 36. Normethadone;
18 37. Norpipanone;
19 38. Phenadoxone;
20 39. Phenampromide;
21 40. Phenomorphan;
22 41. Phenoperidine;
23 42. Piritramide;
24 43. Proheptazine;
Req. No. 10084 Page 3

1 44. Properidine;
2 45. Protonitazene;
3 46. Racemoramide; or
4 47. Trimeperidine.
5 B. Any of the following opium derivatives, their salts,
6 isomers, and salts of isomers, unless specifically excepted, when
7 the existence of these salts, isomers, and salts of isomers is
8 possible within the specific chemical designation:
9 1. Acetorphine;
10 2. Acetyldihydrocodeine;
11 3. Benzylmorphine;
12 4. Codeine methylbromide;
13 5. Codeine-N-Oxide;
14 6. Cyprenorphine;
15 7. Desomorphine;
16 8. Dihydromorphine;
17 9. Etorphine;
18 10. Heroin;
19 11. Hydromorphinol;
20 12. Methyldesorphine;
21 13. Methylhydromorphine;
22 14. Morphine methylbromide;
23 15. Morphine methylsulfonate;
24 16. Morphine-N-Oxide;
Req. No. 10084 Page 4

1 17. Myrophine;
2 18. Nicocodeine;
3 19. Nicomorphine;
4 20. Normorphine;
5 21. Phoclodine;
6 22. Thebacon;
7 23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide
8 (Acetyl fentanyl);
9 24. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butenamide
10 (Crotonyl fentanyl);
11 25. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-
12 furancarboxamide (Furanyl fentanyl);
13 26. N-phenyl-1-(2-phenylethyl)-4-piperidinamine (4-ANPP);
14 27. N-(1-phenethylpiperidin-4-yl)-N-
15 phenylcyclopropanecarboxamide (Cyclopropyl fentanyl); or
16 28. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide
17 (Butyrl fentanyl).
18 C. Any material, compound, mixture, or preparation which
19 contains any quantity of the following hallucinogenic substances,
20 their salts, isomers, and salts of isomers, unless specifically
21 excepted, when the existence of these salts, isomers, and salts of
22 isomers is possible within the specific chemical designation:
23 1. Methcathinone;
24 2. 3, 4-methylenedioxy amphetamine;
Req. No. 10084 Page 5

1 3. 3, 4-methylenedioxy methamphetamine;
2 4. 5-methoxy-3, 4-methylenedioxy amphetamine;
3 5. 3, 4, 5-trimethoxy amphetamine;
4 6. Bufotenine;
5 7. Diethyltryptamine;
6 8. Dimethyltryptamine;
7 9. 4-methyl-2, 5-dimethoxyamphetamine;
8 10. Ibogaine;
9 11. Lysergic acid diethylamide;
10 12. Marijuana;
11 13. Mescaline;
12 14. N-benzylpiperazine;
13 15. N-ethyl-3-piperidyl benzilate;
14 16. N-methyl-3-piperidyl benzilate;
15 17. Psilocybin;
16 18. Psilocyn;
17 19. 2, 5 dimethoxyamphetamine;
18 20. 4 Bromo-2, 5-dimethoxyamphetamine;
19 21. 4 methoxyamphetamine;
20 22. Cyclohexamine;
21 23. Salvia Divinorum;
22 24. Salvinorin A;
23
24
Req. No. 10084 Page 6

1 25. Thiophene Analog of Phencyclidine. Also known as: 1-(1-(2-
2 thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine;
3 TPCP, TCP;
4 26. Phencyclidine (PCP);
5 27. Pyrrolidine Analog for Phencyclidine. Also known as 1-(1-
6 Phenylcyclohexyl) - Pyrrolidine, PCPy, PHP;
7 28. 1-(3-trifluoromethylphenyl) piperazine;
8 29. Flunitrazepam;
9 30. B-hydroxy-amphetamine;
10 31. B-ketoamphetamine;
11 32. 2,5-dimethoxy-4-nitroamphetamine;
12 33. 2,5-dimethoxy-4-bromophenethylamine;
13 34. 2,5-dimethoxy-4-chlorophenethylamine;
14 35. 2,5-dimethoxy-4-iodoamphetamine;
15 36. 2,5-dimethoxy-4-iodophenethylamine;
16 37. 2,5-dimethoxy-4-methylphenethylamine;
17 38. 2,5-dimethoxy-4-ethylphenethylamine;
18 39. 2,5-dimethoxy-4-fluorophenethylamine;
19 40. 2,5-dimethoxy-4-nitrophenethylamine;
20 41. 2,5-dimethoxy-4-ethylthio-phenethylamine;
21 42. 2,5-dimethoxy-4-isopropylthio-phenethylamine;
22 43. 2,5-dimethoxy-4-propylthio-phenethylamine;
23 44. 2,5-dimethoxy-4-cyclopropylmethylthio-phenethylamine;
24 45. 2,5-dimethoxy-4-tert-butylthio-phenethylamine;
Req. No. 10084 Page 7

1 46. 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine;
2 47. 5-methoxy-N, N-dimethyltryptamine;
3 48. N-methyltryptamine;
4 49. A-ethyltryptamine;
5 50. A-methyltryptamine;
6 51. N, N-diethyltryptamine;
7 52. N, N-diisopropyltryptamine;
8 53. N, N-dipropyltryptamine;
9 54. 5-methoxy-a-methyltryptamine;
10 55. 4-hydroxy-N, N-diethyltryptamine;
11 56. 4-hydroxy-N, N-diisopropyltryptamine;
12 57. 5-methoxy-N, N-diisopropyltryptamine;
13 58. 4-hydroxy-N-isopropyl-N-methyltryptamine;
14 59. 3,4-Methylenedioxymethcathinone (Methylone);
15 60. 3,4-Methylenedioxypyrovalerone (MDPV);
16 61. 3-Methylmethcathinone (Metaphedrone);
17 62. 4-Methylmethcathinone (Mephedrone);
18 63. 4-methoxymethcathinone;
19 64. 4-Fluoromethcathinone;
20 65. 3-Fluoromethcathinone;
21 66. 1-(8-bromobenzo 1,2-b;4,5-b' difuran-4-yl)-2-aminopropane;
22 67. 2,5-Dimethoxy-4-chloroamphetamine;
23 68. 4-Methylethcathinone;
24 69. Pyrovalerone;
Req. No. 10084 Page 8

1 70. N,N-diallyl-5-methoxytryptamine;
2 71. 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);
3 72. B-keto-N-Methylbenzodioxolylbutanamine (Butylone);
4 73. B-keto-Methylbenzodioxolylpentanamine (Pentylone);
5 74. Alpha-Pyrrolidinopentiophenone;
6 75. 4-Fluoroamphetamine;
7 76. Pentedrone;
8 77. 4'-Methyl-a-pyrrolidinohexaphenone;
9 78. 2,5-dimethoxy-4-(n)-propylphenethylamine;
10 79. 2,5-dimethoxyphenethylamine;
11 80. 1,4-Dibenzylpiperazine;
12 81. N,N-Dimethylamphetamine;
13 82. 4-Fluoromethamphetamine;
14 83. 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
15 (25C-NBOMe);
16 84. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
17 (25I-NBOMe);
18 85. 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzy)phenethylamine
19 (25B-NBOMe);
20 86. 1-(4-Fluorophenyl)piperazine;
21 87. Methoxetamine;
22 88. 3,4-dichloro-N[2-dimethylamino)cyclohexyl]-N-
23 methylbenzamide;
24 89. N-ethyl hexadrone;
Req. No. 10084 Page 9

1 90. Isopropyl-U-47700;
2 91. Para-fluorobutyrl fentanyl;
3 92. Para-fluorofentanyl (pFF);
4 93. Fluoro isobutryrl fentanyl;
5 94. 3-Hydroxy Phencyclidine (PCP);
6 95. 3-methoxy Phencyclidine (PCP);
7 96. Flualprazolam; or
8 97. Flubromazolam;
9 98. Ethyleneoxynitazene;
10 99. 5-Methyl Etodesnitazene;
11 100. 3', 4' Methylenedioxynitazene;
12 101. N-Pyrrolidino Isotonitazene;
13 102. N-Desethyl Etonitazene; or
14 103. Ethylene Etonitazene.
15 D. Unless specifically excepted or unless listed in a different
16 schedule, any material, compound, mixture, or preparation which
17 contains any quantity of the following substances having stimulant
18 or depressant effect on the central nervous system:
19 1. Fenethylline;
20 2. Mecloqualone;
21 3. N-ethylamphetamine;
22 4. Methaqualone;
23
24
Req. No. 10084 Page 10

1 5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma-
2 hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium
3 oxybate, and sodium oxybutyrate;
4 6. Gamma-Butyrolactone (GBL) as packaged, marketed,
5 manufactured or promoted for human consumption, with the exception
6 of legitimate food additive and manufacturing purposes;
7 7. Gamma Hydroxyvalerate (GHV) as packaged, marketed, or
8 manufactured for human consumption, with the exception of legitimate
9 food additive and manufacturing purposes;
10 8. Gamma Valerolactone (GVL) as packaged, marketed, or
11 manufactured for human consumption, with the exception of legitimate
12 food additive and manufacturing purposes;
13 9. 1,4 Butanediol (1,4 BD or BDO) as packaged, marketed,
14 manufactured, or promoted for human consumption with the exception
15 of legitimate manufacturing purposes; or
16 10. N-ethylpentylone.
17 E. 1. The following industrial uses of Gamma-Butyrolactone,
18 Gamma Hydroxyvalerate, Gamma Valerolactone, or 1,4 Butanediol are
19 excluded from all schedules of controlled substances under this
20 title:
21 a. pesticides,
22 b. photochemical etching,
23 c. electrolytes of small batteries or capacitors,
24 d. viscosity modifiers in polyurethane,
Req. No. 10084 Page 11

1 e. surface etching of metal coated plastics,
2 f. organic paint disbursements for water soluble inks,
3 g. pH regulators in the dyeing of wool and polyamide
4 fibers,
5 h. foundry chemistry as a catalyst during curing,
6 i. curing agents in many coating systems based on
7 urethanes and amides,
8 j. additives and flavoring agents in food, confectionary,
9 and beverage products,
10 k. synthetic fiber and clothing production,
11 l. tetrahydrofuran production,
12 m. gamma butyrolactone production,
13 n. polybutylene terephthalate resin production,
14 o. polyester raw materials for polyurethane elastomers
15 and foams,
16 p. coating resin raw material, and
17 q. as an intermediate in the manufacture of other
18 chemicals and pharmaceuticals.
19 2. At the request of any person, the Director of the Oklahoma
20 State Bureau of Narcotics and Dangerous Drugs Control may exempt any
21 other product containing Gamma-Butyrolactone, Gamma Hydroxyvalerate,
22 Gamma Valerolactone, or 1,4 Butanediol from being included as a
23 Schedule I controlled substance if such product is labeled,
24
Req. No. 10084 Page 12

1 mark eted, manufactured and distributed for legitimate industrial use
2 in a manner that reduces or eliminates the likelihood of abuse.
3 3. In making a determination regarding an industrial product,
4 the Director, after notice and hearing, shall consider the
5 following:
6 a. the history and current pattern of abuse,
7 b. the name and labeling of the product,
8 c. the intended manner of distribution, advertising and
9 promotion of the product, and
10 d. other factors as may be relevant to and consistent
11 with the public health and safety.
12 4. The hearing shall be held in accordance with the procedures
13 of the Administrative Procedures Act.
14 F. Any material, compound, mixture, or preparation, whether
15 produced directly or indirectly from a substance of vegetable origin
16 or independently by means of chemical synthesis, or by a combination
17 of extraction and chemical synthesis, that contains any quantity of
18 the following substances, or that contains any of their salts,
19 isomers, and salts of isomers when the existence of these salts,
20 isomers, and salts of isomers is possible within the specific
21 chemical designation:
22 1. JWH-004;
23 2. JWH-007;
24 3. JWH-009;
Req. No. 10084 Page 13

1 4. JWH-015;
2 5. JWH-016;
3 6. JWH-018;
4 7. JWH-019;
5 8. JWH-020;
6 9. JWH-030;
7 10. JWH-046;
8 11. JWH-047;
9 12. JWH-048;
10 13. JWH-049;
11 14. JWH-050;
12 15. JWH-070;
13 16. JWH-071;
14 17. JWH-072;
15 18. JWH-073;
16 19. JWH-076;
17 20. JWH-079;
18 21. JWH-080;
19 22. JWH-081;
20 23. JWH-082;
21 24. JWH-094;
22 25. JWH-096;
23 26. JWH-098;
24 27. JWH-116;
Req. No. 10084 Page 14

1 28. JWH-120;
2 29. JWH-122;
3 30. JWH-145;
4 31. JWH-146;
5 32. JWH-147;
6 33. JWH-148;
7 34. JWH-149;
8 35. JWH-150;
9 36. JWH-156;
10 37. JWH-167;
11 38. JWH-175;
12 39. JWH-180;
13 40. JWH-181;
14 41. JWH-182;
15 42. JWH-184;
16 43. JWH-185;
17 44. JWH-189;
18 45. JWH-192;
19 46. JWH-193;
20 47. JWH-194;
21 48. JWH-195;
22 49. JWH-196;
23 50. JWH-197;
24 51. JWH-198;
Req. No. 10084 Page 15

1 52. JWH-199;
2 53. JWH-200;
3 54. JWH-201;
4 55. JWH-202;
5 56. JWH-203;
6 57. JWH-204;
7 58. JWH-205;
8 59. JWH-206;
9 60. JWH-207;
10 61. JWH-208;
11 62. JWH-209;
12 63. JWH-210;
13 64. JWH-211;
14 65. JWH-212;
15 66. JWH-213;
16 67. JWH-234;
17 68. JWH-235;
18 69. JWH-236;
19 70. JWH-237;
20 71. JWH-239;
21 72. JWH-240;
22 73. JWH-241;
23 74. JWH-242;
24 75. JWH-243;
Req. No. 10084 Page 16

1 76. JWH-244;
2 77. JWH-245;
3 78. JWH-246;
4 79. JWH-248;
5 80. JWH-249;
6 81. JWH-250;
7 82. JWH-251;
8 83. JWH-252;
9 84. JWH-253;
10 85. JWH-262;
11 86. JWH-292;
12 87. JWH-293;
13 88. JWH-302;
14 89. JWH-303;
15 90. JWH-304;
16 91. JWH-305;
17 92. JWH-306;
18 93. JWH-307;
19 94. JWH-308;
20 95. JWH-311;
21 96. JWH-312;
22 97. JWH-313;
23 98. JWH-314;
24 99. JWH-315;
Req. No. 10084 Page 17

1 100. JWH-316;
2 101. JWH-346;
3 102. JWH-348;
4 103. JWH-363;
5 104. JWH-364;
6 105. JWH-365;
7 106. JWH-367;
8 107. JWH-368;
9 108. JWH-369;
10 109. JWH-370;
11 110. JWH-371;
12 111. JWH-373;
13 112. JWH-386;
14 113. JWH-387;
15 114. JWH-392;
16 115. JWH-394;
17 116. JWH-395;
18 117. JWH-397;
19 118. JWH-398;
20 119. JWH-399;
21 120. JWH-400;
22 121. JWH-412;
23 122. JWH-413;
24 123. JWH-414;
Req. No. 10084 Page 18

1 124. JWH-415;
2 125. CP-55, 940;
3 126. CP-47, 497;
4 127. HU-210;
5 128. HU-211;
6 129. WIN-55, 212-2;
7 130. AM-2201;
8 131. AM-2233;
9 132. JWH-018 adamantyl-carboxamide;
10 133. AKB48;
11 134. JWH-122 N-(4-pentenyl)analog;
12 135. MAM2201;
13 136. URB597;
14 137. URB602;
15 138. URB754;
16 139. UR144;
17 140. XLR11;
18 141. A-796,260;
19 142. STS-135;
20 143. AB-FUBINACA;
21 144. AB-PINACA;
22 145. PB-22;
23 146. AKB48 N-5-Fluorpentyl;
24 147. AM1248;
Req. No. 10084 Page 19

1 148. FUB-PB-22;
2 149. ADB-FUBINACA;
3 150. BB-22;
4 151. 5-Fluoro PB-22; or
5 152. 5-Fluoro AKB-48.
6 G. In addition to those substances listed in subsection F of
7 this section, unless specifically excepted or unless listed in
8 another schedule, any material, compound, mixture, or preparation
9 which contains any quantity of a synthetic cannabinoid found to be
10 in any of the following chemical groups:
11 1. Naphthoylindoles: any compound containing a 3-(1-
12 naphthoyl)indole structure with or without substitution at the
13 nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,
14 alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-
15 (N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-
16 2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
17 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
18 halophenyl group, whether or not further substituted on the indole
19 ring to any extent, and whether or not substituted on the naphthyl
20 ring to any extent. Naphthoylindoles include, but are not limited
21 to:
22 a. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-
23 200),
24 b. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),
Req. No. 10084 Page 20

1 c. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),
2 d. 1-butyl-3-(1-naphthoyl)indole (JWH-073),
3 e. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),
4 f. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),
5 g. 1-hexyl-3-(1-naphthoyl)indole (JWH-019),
6 h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122),
7 i. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210),
8 j. 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398),
9 k. 1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH-007),
10 l. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole (JWH-164),
11 m. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole
12 (JWH-098),
13 n. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole (JWH-412),
14 o. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-
15 naphthoyl)indole (AM-1220),
16 p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole
17 (MAM-2201), or
18 q. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole (AM-2232);
19 2. Naphthylmethylindoles: any compound containing a 1H-indol-
20 3-yl-(1-naphthyl)methane structure with or without substitution at
21 the nitrogen atom of the indole ring by an alkyl, haloalkyl,
22 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
23 halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
24 morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
Req. No. 10084 Page 21

1 morp holinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
2 phenyl, or halophenyl group, whether or not further substituted on
3 the indole ring to any extent, and whether or not substituted on the
4 naphthyl ring to any extent. Naphthylmethylindoles include, but are
5 not limited to, (1-pentylindol-3-yl)(1-naphthyl)methane (JWH-175);
6 3. Naphthoylpyrroles: any compound containing a 3-(1-
7 naphthoyl)pyrrole structure with or without substitution at the
8 nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,
9 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
10 halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
11 morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
12 morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
13 phenyl, or halophenyl group, whether or not further substituted on
14 the pyrrole ring to any extent, and whether or not substituted on
15 the naphthyl group to any extent. Naphthoylpyrroles include, but
16 are not limited to:
17 a. 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147),
18 b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole
19 (JWH-370),
20 c. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH-030), or
21 d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH-147);
22 4. Naphthylideneindenes: any compound containing a 1-(1-
23 naphthylmethylene)indene structure with or without substitution at
24 the 3-position of the indene ring by an alkyl, haloalkyl,
Req. No. 10084 Page 22

1 cyan oalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
2 halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
3 morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
4 morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
5 phenyl, or halophenyl group, whether or not further substituted on
6 the indene group to any extent, and whether or not substituted on
7 the naphthyl group to any extent. Naphthylmethylindenes include,
8 but are not limited to, (1-[(3-pentyl)-1H-inden-1-
9 ylidene)methyl]naphthalene (JWH-176);
10 5. Phenylacetylindoles: any compound containing a 3-
11 phenylacetylindole structure with or without substitution at the
12 nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,
13 alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-
14 (N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-
15 2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
16 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
17 halophenyl group, whether or not further substituted on the indole
18 ring to any extent, and whether or not substituted on the phenyl
19 ring to any extent. Phenylacetylindoles include, but are not
20 limited to:
21 a. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250),
22 b. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole
23 (RCS-8),
24 c. 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203),
Req. No. 10084 Page 23

1 d. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251),
2 e. 1-pentyl-3-(4-methoxyphenylacetyl)indole (JWH-201), or
3 f. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302);
4 6. Cyclohexylphenols: any compound containing a 2-(3-
5 hydroxycyclohexyl)phenol structure with or without substitution at
6 the 5-position of the phenolic ring by an alkyl, haloalkyl,
7 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
8 halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
9 morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
10 morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
11 phenyl, or halophenyl group, and whether or not further substituted
12 on the cyclohexyl ring to any extent. Cyclohexylphenols include,
13 but are not limited to:
14 a. 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-
15 hydroxycyclohexyl]-phenol (CP-47,497),
16 b. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-
17 phenol (cannabicyclohexanol; CP-47,497 C8 homologue),
18 or
19 c. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-
20 hydroxypropyl)cyclohexyl]-phenol (CP 55, 940);
21 7. Benzoylindoles: any compound containing a 3-(benzoyl)indole
22 structure with or without substitution at the nitrogen atom of the
23 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
24 cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
Req. No. 10084 Page 24

1 2-pi peridinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
2 pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
3 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
4 halophenyl group, whether or not further substituted on the indole
5 ring to any extent, and whether or not substituted on the phenyl
6 group to any extent. Benzoylindoles include, but are not limited
7 to:
8 a. 1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4),
9 b. 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-
10 methoxybenzoyl)indole (Pravadoline or WIN 48, 098),
11 c. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694),
12 d. 1-pentyl-3-(2-iodobenzoyl)indole (AM-679), or
13 e. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-
14 iodobenzoyl)indole (AM-2233);
15 8. Cyclopropoylindoles: Any compound containing a 3-
16 (cyclopropoyl)indole structure with substitution at the nitrogen
17 atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
18 cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
19 2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
20 pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
21 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
22 halophenyl group, whether or not further substituted in the indole
23 ring to any extent and whether or not substituted in the
24
Req. No. 10084 Page 25

1 cycl opropoyl ring to any extent. Cyclopropoylindoles include, but
2 are not limited to:
3 a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole
4 (UR-144),
5 b. 1-(5-chloropentyl)-3-(2,2,3,3-
6 tetramethylcyclopropoyl)indole (5Cl-UR-144), or
7 c. 1-(5-fluoropentyl)-3-(2,2,3,3-
8 tetramethylcyclopropoyl)indole (XLR11);
9 9. Indole Amides: Any compound containing a 1H-Indole-3-
10 carboxamide structure with or without substitution at the nitrogen
11 atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
12 cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
13 2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
14 pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
15 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
16 halophenyl group, whether or not substituted at the carboxamide
17 group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
18 cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
19 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
20 dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
21 further substituted in the indole, adamantyl, naphthyl, phenyl,
22 pyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole
23 Amides include, but are not limited to:
24
Req. No. 10084 Page 26

1 a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide
2 (2NE1),
3 b. N-(1-adamantyl)-1-(5-fluoropentyl-1H-indole-3-
4 carboxamide (STS-135),
5 c. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
6 indole-3-carboxamide (ADBICA),
7 d. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-
8 fluoropentyl)-1H-indole-3-carboxamide (5F-ADBICA),
9 e. N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide
10 (NNE1),
11 f. 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-
12 carboxamide (5F-NNE1),
13 g. N-benzyl-1-pentyl-1H-indole-3-carboxamide (SDB-006),
14 or
15 h. N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
16 (5F-SDB-006);
17 10. Indole Esters: Any compound containing a 1H-Indole-3-
18 carboxylate structure with or without substitution at the nitrogen
19 atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
20 cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
21 2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
22 pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,
23 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
24 halophenyl group, whether or not substituted at the carboxylate
Req. No. 10084 Page 27

1 grou p by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
2 cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
3 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
4 dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
5 further substituted in the indole, adamantyl, naphthyl, phenyl,
6 pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole
7 Esters include, but are not limited to:
8 a. quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-
9 22),
10 b. quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-
11 carboxylate (5F-PB-22),
12 c. quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-
13 carboxylate (BB-22),
14 d. naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-
15 carboxylate (FDU-PB-22), or
16 e. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-
17 carboxylate (NM2201);
18 11. Adamantanoylindoles: Any compound containing an
19 adamantanyl-(1H-indol-3-yl)methanone structure with or without
20 substitution at the nitrogen atom of the indole ring by an alkyl,
21 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
22 benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
23 morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
24 morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
Req. No. 10084 Page 28

1 phen yl, or halophenyl group, whether or not further substituted in
2 the indole ring to any extent and whether or not substituted in the
3 adamantyl ring to any extent. Adamantanoylindoles include, but are
4 not limited to:
5 a. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-
6 indol-3-yl]methanone (AM1248), or
7 b. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-
8 001);
9 12. Carbazole Ketone: Any compound containing (9H-carbazole-3-
10 yl) methanone structure with or without substitution at the nitrogen
11 atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl,
12 alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-
13 (N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-
14 2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,
15 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
16 halophenyl group, with substitution at the carbon of the methanone
17 group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
18 cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
19 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
20 dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
21 further substituted at the carbazole, adamantyl, naphthyl, phenyl,
22 pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole
23 Ketones include, but are not limited to, naphthalen-1-yl(9-pentyl-
24 9H-carbazol-3-yl)methanone (EG-018);
Req. No. 10084 Page 29

1 13. Benzimidazole Ketone: Any compound containing
2 (benzimidazole-2-yl) methanone structure with or without
3 substitution at either nitrogen atom of the benzimidazole ring by an
4 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
5 cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-
6 piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
7 pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,
8 (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
9 halophenyl group, with substitution at the carbon of the methanone
10 group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
11 cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
12 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
13 dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
14 further substituted in the benzimidazole, adamantyl, naphthyl,
15 phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent.
16 Benzimidazole Ketones include, but are not limited to:
17 a. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-
18 l)methanone (JWH-018 benzimidazole analog), or
19 b. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-
20 yl)(naphthalen-1-yl)methanone (FUBIMINA); and
21 14. Modified by Replacement: any compound defined in this
22 subsection that is modified by replacement of a carbon with nitrogen
23 in the indole, naphthyl, indene, benzimidazole, or carbazole ring.
24
Req. No. 10084 Page 30

1 H. Any prescription drug approved by the federal Food and Drug
2 Administration under the provisions of Section 505 of the Federal
3 Food, Drug and Cosmetic Act, Title 21 of the United States Code,
4 Section 355, that is designated, rescheduled or deleted as a
5 controlled substance under federal law by the United States Drug
6 Enforcement Administration shall be excluded from Schedule I and
7 shall be prescribed, distributed, dispensed or used in accordance
8 with federal law upon the issuance of a notice, final rule or
9 interim final rule by the United States Drug Enforcement
10 Administration designating, rescheduling or deleting as a controlled
11 substance such a drug product under federal law, unless and until
12 the State Board of Pharmacy takes action pursuant to Section 2-201
13 of this title. If the Board of Pharmacy does not take action
14 pursuant to Section 2-201 of this title, the drug product shall be
15 deemed to be designated, rescheduled or deleted as a controlled
16 substance in accordance with federal law and in compliance with the
17 Uniform Controlled Dangerous Substances Act.
18 SECTION 2. This act shall become effective November 1, 2025.
19
20 60-1-10084 GRS 12/31/24
21
22
23
24
Req. No. 10084 Page 31

[DELETED:  P B]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P p p e v]
[DELETED:  P s o p f c a s t g p p c a]
[DELETED:  P t t t o]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P 1 1]
[DELETED:  P 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED:  P 1 1 1 1]
[DELETED:  P 1 1 1]
[DELETED:  P 1 1 1 5 5 5]
[DELETED:  P 1 1 1 1 1]
[DELETED:  P 1 1 1]
[DELETED:  P N N N N N 1 N N]
[DELETED:  P q q q n n]
[DELETED:  P a a]
[DELETED:  P n (]
[DELETED:  P G 1]